Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
Year: 2020
Type: article
Abstract: The hypoxia and profound inflammatory response associated with the pneumonitis observed with the SARS-CoV-2 virus responsible for the recent COVID-19 pandemic has overwhelmed intensive care facilities in the epicenters of infection including Wuhan, China, Northern Italy and in the USA, the Seattle
Authors: Paolo Antonio Ascierto, Bernard A Fox, Walter J Urba, Ana Carrizosa Anderson, Michael B Atkins, Ernest C Borden, Julie R Brahmer, Lisa H Butterfield, Alessandra Cesano, Daniel S Chen, Tanja D de Gruijl, Robert O Dillman, Charles G Drake, Leisha A Emens, Thomas F Gajewski, James L Gulley, F Stephen Hodi Jr, Patrick Hwu, David Kaufman, Howard L Kaufman, Michael T Lotze, Douglas G McNeel, Kim A Margolin, Francesco M Marincola, Michael J Mastrangelo, Marcela V Maus, David R Parkinson, Pedro J Romero, Paul M Sondel, Stefani Spranger, Mario Sznol, George J Weiner, Jon M Wigginton, Jeffrey S Weber
Institutions: Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Harvard University, Georgetown Lombardi Comprehensive Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Essa Pharma (United States), IGM Biosciences (United States), Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, University of Chicago, National Institutes of Health, National Cancer Institute, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, Immuneering (United States), University of Pittsburgh, City Of Hope National Medical Center, Refuge Biotechnologies (United States), Massachusetts General Hospital, University of Lausanne, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, Yale Cancer Center, Yale University, University of Iowa, University of Iowa Health Care, University of Iowa Holden Comprehensive Cancer Center, MacroGenics (United States), NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W3017340845